Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 363 of the 363 references it cites were found in a registry or an index.

Targeting the tumour stroma to improve cancer therapy

Open access
Valkenburg, Kenneth C., de Groot, Amber E., Pienta, Kenneth J. · 2018 · Nature Reviews Clinical Oncology

Abstract

Cancers are not composed merely of cancer cells alone; instead, they are complex ‘ecosystems’ comprising many different cell types and noncellular factors. The tumour stroma is a critical component of the tumour microenvironment, where it has crucial roles in tumour initiation, progression, and metastasis. Most anticancer therapies target cancer cells specifically, but the tumour stroma can promote the resistance of cancer cells to such therapies, eventually resulting in fatal disease. Therefore, novel treatment strategies should combine anticancer and antistromal agents. Herein, we provide an overview of the advances in understanding the complex cancer cell–tumour stroma interactions and discuss how this knowledge can result in more effective therapeutic strategies, which might ultimately improve patient outcomes.Key pointsTumours comprise cancer cells as well as a stromal compartment with cellular and noncellular components.The tumour stroma has critical roles in cancer development, progression, and metastasis.Typically, anticancer therapies predominantly target cancer cells, and their effect on the tumour stroma is not taken into account.The tumour stroma responds to anticancer therapies by inducing therapeutic resistance, which can ultimately lead to fatal disease.Anticancer therapies should target both cancer cells and the stromal compartment to be effective and result in improved patient outcomes.The tumour stroma is a component of the tumour microenvironment and has cr…

Overview

Integrity signals

Registry

Crossref · 10.1038/s41571-018-0007-1

Cites

363 of 363 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

2 retracted

Show all 363 references

Cited by

See all 1,084

Metadata

Authors
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J.
Affiliations
Johns Hopkins University (US)
Corresponding author
Valkenburg, Kenneth C.
Venue
Nature Reviews Clinical Oncology
Published
2018-04-12
Volume
15
Issue
6
Pages
366-381
ISSN
  • 1759-4774 (ISSN-L)
  • 1759-4782
OpenAlex
W2796997430
Cited by
1,084
References
363
Citations by year
2026: 80 · 2025: 138 · 2024: 135 · 2023: 149 · 2022: 175 · 2021: 181 · 2020: 124 · 2019: 82 · 2018: 19
FWCI
10.65
Type
journal article
Language
en
Open access
Licence
www.springer.com/tdm (tdm)
Locations
  • Nature Reviews Clinical Oncology (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Prostate Cancer Foundation
  • National Cancer Institute (U54CA163124, U01CA196390, P01CA093900, U01CA143055, U54CA143803, F32CA206394)
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
Keywords
tumor stroma, tumor microenvironment, combination therapy, cancer therapy resistance, tumor progression, metastasis, tumor initiation
MeSH terms
Antineoplastic Combined Chemotherapy Protocols, Humans, Neoplasms, Stromal Cells, Cell Lineage, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Targeting the tumour stroma to improve cancer therapy. https://app.cochat.ai/papers/10.1038/s41571-018-0007-1
The paper
Valkenburg, K. C., de Groot, A. E., & Pienta, K. J. (2018). Targeting the tumour stroma to improve cancer therapy. Nature Reviews Clinical Oncology. https://doi.org/10.1038/s41571-018-0007-1

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.